13.01.2020
Supplemental data to the manuscript by Vockova et al "Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma"
number of views: 464
last modification: 13.01.2020
Page ranking:
If you think the article is not up-to-date, click here.